JLJayne Lewis-Kulzer

Jayne Lewis-Kulzer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jayne Lewis-Kulzer has a total of 91 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Systematic dissemination of study findings from local to national stakeholders: a case of a social network-based study on HIV self-testing and linkage among fishermen in Kenya

    by Benard O. Ayieko, Edwin D. Charlebois, Lila A. Sheira, Sarah A. Gutin, Phoebe Olugo, Jayne Lewis-Kulzer, Zachary A. Kwena, Harsha Thirumurthy, Kawango Agot, Carol S. Camlin

  • Open Access

    Delays in Tuberculosis Treatment Among People With Pulmonary Tuberculosis in East Africa: Findings From a Prospective Cohort Study

    by Kirsten Prabhudas-Strycker, Lameck Diero, Winnie Muyindike, Helen Byakwaga, Sylvia Kitur, Joseph Mining’WO, Bob Ssekyanzi, Alexis Byaruhanga, Harold Kooreman, Felix Pabon-Rodriguez, et al.

    Background: Although timely tuberculosis (TB) diagnosis and treatment are essential to TB elimination, care delays remain a challenge. Understanding factors associated with delayed TB diagnosis and treatment may inform interventions. Methods: The TB Sentinel Research Network of the International epidemiology Databases to Evaluate AIDS (IeDEA) is a prospective study of people aged ≥15 years with pulmonary TB. At sites in Eldoret, Kenya, and Mbarara, Uganda, questionnaires ascertained timing of recalled TB symptom onset, number/setting of healthcare visits prior to TB diagnosis, symptoms, demographics, food insecurity, and TB- and HIV-related stigma. Robust negative binomial regression was used to examine factors associated with longer overall duration from TB symptom onset to documented treatment initiation. Results: Among 264 participants—median age 33 years (IQR, 25–43 years), 67% male, 31% people with HIV, 51% urban residents—median duration from TB symptom onset to treatment initiation was 65.5 days (IQR, 33–131 days). Longer time to TB treatment was associated with female sex (adjusted incidence rate ratio [aIRR], 1.27 [95% CI, 1.00–1.61]); previous care-seeking at a pharmacy (aIRR, 1.53 [95% CI, 1.22–1.92]), and presence of dyspnea (aIRR, 1.43 [95% CI, 1.09–1.86]) or fatigue (aIRR, 1.63 [95% CI, 1.11–2.37]) at initiation. Shorter duration to TB treatment was associated with HIV-positive status (aIRR, 0.50 [95% CI, .39–.64]). Among people with HIV, shorter duration to TB treatment was associated with CD4 count <200 cells/μL (aIRR, 0.63 [95% CI, .43–.93]). Conclusions: Interventions are needed to increase community-level TB diagnostic access, including at pharmacies and lower levels of care. Decentralized TB testing strategies and tailored interventions for groups with lower care access should be pursued.

  • Open Access

    HIVST in the presence of a partner among fishermen in Western Kenya: A qualitative study

    by Peter Abade, Phoebe Olugo, Sarah A. Gutin, Holly Nishimura, Jayne Lewis-Kulzer, Marguerite Thorp, Benard Ayieko, Lennah Oluoch, David Angawa, Carol S. Camlin, et al.

    HIV self-testing (HIVST) enables individuals to test privately and can serve as an important tool to mitigate stigma and fear of HIV testing and unintended disclosure, especially among men, who have lower voluntary testing rates than women. Within an intervention study involving distribution of HIVST kits by fishermen to their peers [NCT04772469], we explore the experiences and the motivations of men who chose to self-test for HIV in the presence of their female partners. We conducted in-depth interviews (n = 32) with fishermen from three fishing communities along Lake Victoria, Kenya. Interviews were conducted at three months post-intervention and explored fishermen's experiences with HIVST and the context under which they tested. Interviews were analysed using a framework analysis approach. Though they were not prompted by the study to do so, 17 participants described testing for HIV at home in the presence of partners. Fishermen who used HIVST kits in front of partners expressed feelings of comfort and closeness, felt the experience strengthened their relationships, helped garner partner support, and facilitated partner disclosure of their HIV status and subsequent couples' HIV testing. Building awareness of the benefits of HIVST for promoting knowledge of HIV status, as a starting point for discussions about HIV, and to promote disclosure in relationships, may increase rates of voluntary HIV testing among men.


  • Open Access

    Effectiveness and experiences with differentiated service delivery of HIV care in Kisumu County, Kenya: A mixed methods study, 2014–2021

    by Francesca Odhiambo, Raphael Onyango Mando, Jayne Lewis-Kulzer, A. Rain Mocello, Maurice Aluda, Edwin Mulwa, Appolonia Aoko, Paul Musingila, Elizabeth Bukusi, Craig R. Cohen

    The adoption of the test and treat policy by the World Health Organization (WHO) in 2015 led to an unprecedented increase in the number of people living with HIV (PLHIV) enrolling into HIV treatment, thereby increasing the burden on HIV service delivery. To compensate, WHO endorsed the Differentiated Service Delivery (DSD) approach to reduce the burden on the health care system and therefore support attainment of the UNAIDS 95-95-95 goals by 2030. This study examined clinical outcomes among clients enrolled in the DSD models and examined health care worker and client experiences of the DSD approach. A client-level pre-post study was conducted in 14 Ministry of Health (MOH) facilities in Kisumu County from October 2014 – March 2021 to examine retention and viral load suppression (<1000 copies/mL) in a cohort of stable clients aged 20 years and above at three time points: immediately preceding DSD start (pre-DSD; 2014–2016), 12 months post-DSD implementation (midline), and 24 months post-DSD (endline). Focus group discussions (FGDs) were conducted to assess DSD experiences among a sample of adult clients and health care workers. Findings from the pre-post analysis showed a significant increase in retention at 12 months (99.2%) and 24 months (98.9%) compared to pre-DSD (86.4%; p < 0.001). The predominant themes shared by clients and healthcare workers in FGDs were high satisfaction with DSD due to the efficiency of services, improved staff attitudes, and reduced clinic workload. Clients also expressed a strong preference for facility-based models owing to perceived stigma and privacy concerns associated with community DSD models. This study provides important insights on the promising effectiveness of DSD models on sustained retention on ART and viral suppression and the acceptability of this modality for client-centered HIV care.


  • Open Access

    Experiences and perceptions of conditional cash incentive provision and cessation among people with HIV for care engagement: A qualitative study

    by Julia Giordano, Jayne Lewis-Kulzer, Lina Montoya, Eliud Akama, Harriet Fridah Adhiambo, Everlyne Nyadieka, Sarah Iguna, Elizabeth A. Bukusi, Thomas Odeny, Carol S. Camlin, et al.

    Background Consistent engagement in HIV treatment is needed for healthy outcomes, yet substantial loss-to-follow up persists, leading to increased morbidity, mortality and onward transmission risk. Although conditional cash transfers (CCTs) address structural barriers, recent findings suggest that incentive effects are time-limited, with cessation resulting in HIV care engagement deterioration. We explored incentive experiences, perceptions, and effects after cessation to investigate potential mechanisms of this observation. Methods This qualitative study was nested within a larger trial, AdaPT-R (NCT02338739), focused on HIV care engagement in western Kenya. A subset of participants were purposively sampled from AdaPT-R participants: adults with HIV who had recently started ART, received CCTs for one year, completed one year of follow-up without missing a clinic visit, and were randomized to either continue or discontinue CCTs for one more year of follow-up. In-depth interviews were conducted by an experienced qualitative researcher using a semi-structed guide within a month of randomization. Interviews were conducted in the participants’ preferred language (Dholuo, Kiswahili, English). Data on patient characteristics, randomization dates, and clinic visit dates to determine care lapses were extracted from the AdaPT-R database. A codebook was developed deductively based on the guide and inductively refined based on initial transcripts. Transcripts were coded using Dedoose software, and thematic saturation was identified. Results Of 38 participants, 15 (39%) continued receiving incentives, while 23 (61%) were discontinued from receiving incentives. Half were female (N = 19), median age was 30 years (range: 19–48), and about three-quarters were married or living with partners. Both groups expressed high intrinsic motivation to engage in care, prioritized clinic attendance regardless of CCTs and felt the incentives expanded their decision-making options. Despite high motivation, some participants reported that cessation of the CCTs affected their ability to access care, especially those with constrained financial situations. Participants also expressed concerns that incentives might foster dependency. Conclusions This study helps us better understand the durability of financial incentives for HIV care engagement, including when incentives end. Together with the quantitative findings in the parent AdaPT-R study, these results support the idea that careful consideration be exercised when implementing incentives for sustainable engagement effects.

  • Open Access

    Patient perceptions of facilitators and barriers to reducing hazardous alcohol use among people living with HIV in East Africa

    by Jayne Lewis-Kulzer, Margaret Mburu, Sarah Obatsa, Julius Cheruiyot, Lorna Kiprono, Steve Brown, Cosmas Apaka, Hillary Koros, Winnie Muyindike, Edith Kamaru Kwobah, et al.

    Hazardous alcohol use among people living with HIV is associated with poor outcomes and increased morbidity and mortality. Understanding the hazardous drinking experiences of people living with HIV is needed to reduce their alcohol use. We conducted 60 interviews among people living with HIV in East Africa with hazardous drinking histories. Interviews and Alcohol Use Disorder Identification Test (AUDIT) scores were conducted 41 – 60 months after their baseline assessment of alcohol use to identify facilitators and barriers to reduced alcohol use over time. People living with HIV who stopped or reduced hazardous drinking were primarily motivated by their HIV condition and desire for longevity. Facilitators of reduced drinking included health care workers’ recommendations to reduce drinking (despite little counseling and no referrals) and social support. In those continuing to drink at hazardous levels, barriers to reduced drinking were stress, social environment, alcohol accessibility and alcohol dependency. Interventions that capacity-build professional and lay health care workers with the skills and resources to decrease problematic alcohol use, along with alcohol cessation in peer support structures, should be explored.


  • Open Access

    Attitudes towards and experiences with economic incentives for engagement in HIV care and treatment: Qualitative insights from a randomized trial in Kenya

    by Sarah Iguna, Monica Getahun, Jayne Lewis-Kulzer, Gladys Odhiambo, Fridah Adhiambo, Lina Montoya, Maya L. Petersen, Elizabeth Bukusi, Thomas Odeny, Elvin Geng, et al.

    Growing literature has shown heterogenous effects of conditional cash incentives (CCIs) on HIV care retention. The field lacks insights into reasons why incentives impact various patients in different ways–differences that may be due to variations in psychological and social mechanisms of effect. A deeper understanding of patients’ perceptions and experiences of CCIs for retention may help to clarify these mechanisms. We conducted a qualitative study embedded in the ADAPT-R trial (NCT#02338739), a sequential multiple assignment randomized trial (SMART) that evaluated economic incentives to support retention in HIV care among persons living with HIV (PLHIV) initiating antiretroviral therapy in Kenya. Participants who attended their scheduled clinic visits received an incentive of approximately $4 each visit. Interviews were conducted between July 2016 and June 2017 with 39 participants to explore attitudes and experiences with economic incentives conditional on care engagement. Analyses revealed that incentives helped PLHIV prioritize care-seeking by alleviating transport barriers and food insecurity: “I decided to forgo [work] and attend clinic […] the voucher relieved me”. Patients who borrowed money for care-seeking reported feeling relieved from the burden of indebtedness to others: “I borrow with confidence that I will pay after my appointment.” Incentives fostered their autonomy, and enabled them to support others: “I used the money to buy some clothes and Pampers for the children.” Participants who were intrinsically motivated to engage in care (“my life depends on the drugs, not the incentive”), and those who mistrusted researchers, reported being less prompted by the incentive itself. For patients not already prioritizing care-seeking, incentives facilitated care engagement through alleviating transport costs, indebtedness and food insecurity, and also supported social role fulfillment. Conditional cash incentives may be an important cue to action to improve progression through the HIV treatment cascade, and contribute to better care retention.


  • Open Access

    Lower rates of ART initiation and decreased retention among ART-naïve patients who consume alcohol enrolling in HIV care and treatment programs in Kenya and Uganda

    by Ioannis Patsis, Suzanne Goodrich, Constantin T. Yiannoutsos, Steven A. Brown, Beverly S. Musick, Lameck Diero, Jayne L. Kulzer, Mwembesa Bosco Bwana, Patrick Oyaro, Kara K. Wools-Kaloustian

    Almost 13 million people are estimated to be on antiretroviral therapy in Eastern and Southern Africa, and their disease course and program effectiveness could be significantly affected by the concurrent use of alcohol. Screening for alcohol use may be important to assess the prevalence of alcohol consumption and its impact on patient and programmatic outcomes. As part of this observational study, data on patient characteristics and alcohol consumption were collected on a cohort of 765 adult patients enrolling in HIV care in East Africa. Alcohol consumption was assessed with the AUDIT questionnaire at enrollment. Subjects were classified as consuming any alcohol (AUDIT score >0), hazardous drinkers (AUDIT score ≥8) and hyper drinkers (AUDIT score ≥16). The effects of alcohol consumption on retention in care, death and delays in antiretroviral therapy (ART) initiation were assessed through competing risk (Fine & Gray) models. Of all study participants, 41.6% consumed alcohol, 26.7% were classified as hazardous drinkers, and 16.0% as hyper drinkers. Depending on alcohol consumption classification, men were 3–4 times more likely to consume alcohol compared to women. Hazardous drinkers (median age 32.8 years) and hyper drinkers (32.7 years) were slightly older compared to non-hazardous drinkers (30.7 years) and non-hyper drinkers (30.8 years), (p-values = 0.014 and 0.053 respectively). Median CD4 at enrollment was 330 cells/μl and 16% were classified World Health Organization (WHO) stage 3 or 4. There was no association between alcohol consumption and CD4 count or WHO stage at enrollment. Alcohol consumption was associated with significantly lower probability of ART initiation (adjusted sub-distribution hazard ratio aSHR = 0.77 between alcohol consumers versus non-consumers; p-value = 0.008), and higher patient non-retention in care (aSHR = 1.77, p-value = 0.023). Alcohol consumption is associated with significant delays in ART initiation and reduced retention in care for patients enrolling in HIV care and treatment programs in East Africa. Consequently, interventions that target alcohol consumption may have a significant impact on the HIV care cascade.


  • They are likely to be there: using a family-centered index testing approach to identify children living with HIV in Kenya

    by Nicollate Okoko, Jayne L Kulzer, Kristen Ohe, Margaret Mburu, Hellen Muttai, Lisa L Abuogi, Elizabeth A Bukusi, Craig R Cohen, Jeremy Penner

    In Kenya, only half of children with a parent living with HIV have been tested for HIV. The effectiveness of family-centered index testing to identify children (0–14 years) living with HIV was examined. A retrospective record review was conducted among adult index patients newly enrolled in HIV care between May and July 2015; family testing, results, and linkage to treatment outcomes were followed through May 2016 at 60 high-volume clinics in Kenya. Chi square test compared yield (percentage of HIV tests positive) among children tested through family-centered index testing, outpatient and inpatient testing. Review of 1937 index client charts led to 3005 eligible children identified for testing. Of 2848 (94.8%) children tested through family-centered index testing, 127 (4.5%) had HIV diagnosed, 100 (78.7%) were linked to care, and 85 of those eligible (91.4%) initiated antiretroviral therapy (ART).Family testing resulted in higher yield compared to inpatient (1.8%, p < 0.001) or outpatient testing (1.6%, p < 0.001). The absolute number of children living with HIV identified was highest with outpatient testing. The relative contribution of testing approach to total children identified with HIV was outpatient testing (69%), family testing (26%), and inpatient testing (5%). The family testing approach demonstrated promise in achieving the first two “90s” (identification and ART initiation) of the 90–90–90 targets for children, with additional effort required to improve linkage from testing to treatment.


  • Open Access

    Treatment Buddies Improve Clinic Attendance among Women but Not Men on Antiretroviral Therapy in the Nyanza Region of Kenya

    by Charles Kibaara, Cinthia Blat, Jayne Lewis-Kulzer, Starley Shade, Patrick Mbullo, Craig R. Cohen, Elizabeth A. Bukusi

    Background.Kenyan antiretroviral (ART) guidelines encourage treatment buddies (TBy) to maximize treatment adherence. This study examined the effect of TBys on clinic attendance in men and women on ART.Methods.This retrospective cohort study included all adult patients initiating ART from August 2007 to December 2011 at four health facilities in Kenya. Data were abstracted from electronic medical records and analyzed using Poisson regression.Results.Of 2,430 patients, 2,199 (91%) had a TBy. Relationship between TBy and clinic attendance differed in females and males (interactionp=0.09). After demographic and clinic factor adjustment, females with a TBy were 28% more likely to adhere to all appointments than those without (adjusted aRR = 1.28; 95% CI 1.08–1.53), whereas males were no more likely to adhere (aRR = 1.01; 95% CI 0.76–1.32). Males reported partner/spouse (33%) or brother (11%) as the TBy while females reported sister (17%), partner/spouse (14%), or another family member (12%). Multivariable analysis found no association between clinic attendance and TBy relationship in either gender.Conclusion.Clinic attendance was higher among women with TBys but not men. Results support TBys to help women achieve ART success; alternate strategies to bolster TBy benefits are needed for men.